Literature DB >> 18762520

Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection.

Caroline Breese Hall1, Mary T Caserta, Kenneth Schnabel, Lynne M Shelley, Andrea S Marino, Jennifer A Carnahan, Christina Yoo, Geraldine K Lofthus, Michael P McDermott.   

Abstract

OBJECTIVE: We examined the frequency and characteristics of chromosomally integrated human herpesvirus 6 among congenitally infected children.
METHODS: Infants with and without congenital human herpesvirus 6 infection were prospectively monitored. Cord blood mononuclear cell, peripheral blood mononuclear cell, saliva, urine, and hair follicle samples were examined for human herpesvirus 6 DNA. Human herpesvirus 6 RNA, serum antibody, and chromosomally integrated human herpesvirus 6 levels were also assessed.
RESULTS: Among 85 infants, 43 had congenital infections and 42 had postnatal infections. Most congenital infections (86%) resulted from chromosomally integrated human herpesvirus 6; 6 infants (14%) had transplacental infections. Children with chromosomally integrated human herpesvirus 6 had high viral loads in all sites (mean: 5-6 log(10) genomic copies per mug of cellular DNA); among children with transplacental infection or postnatal infection, human herpesvirus 6 DNA was absent in hair samples and inconsistent in other samples, and viral loads were significantly lower. One parent of each child with chromosomally integrated human herpesvirus 6 who had parental hair samples tested had hair containing human herpesvirus 6 DNA. Variant A caused 32% of chromosomally integrated human herpesvirus 6 infections, compared with 2% of postnatal infections. Replicating human herpesvirus 6 was detected only among chromosomally integrated human herpesvirus 6 samples (8% of cord blood mononuclear cells and peripheral blood mononuclear cells). Cord blood human herpesvirus 6 antibody levels were similar among children with chromosomally integrated human herpesvirus 6, transplacental infection, and postnatal infection and between children with maternal and paternal chromosomally integrated human herpesvirus 6 transmission.
CONCLUSIONS: Human herpesvirus 6 congenital infection results primarily from chromosomally integrated virus which is passed through the germ-line. Infants with chromosomally integrated human herpesvirus 6 had high viral loads in all specimens, produced human herpesvirus 6 antibody, and mRNA. The clinical relevance needs study as 1 of 116 newborns may have chromosomally integrated human herpesvirus 6 blood specimens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762520     DOI: 10.1542/peds.2007-2838

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  54 in total

1.  Early developmental outcomes of children with congenital HHV-6 infection.

Authors:  Mary T Caserta; Caroline B Hall; Richard L Canfield; Philip Davidson; Gerry Lofthus; Kenneth Schnabel; Jennifer Carnahan; Lynne Shelley; Hongyue Wang
Journal:  Pediatrics       Date:  2014-11-03       Impact factor: 7.124

2.  Development of a human herpesvirus 6 species-specific immunoblotting assay.

Authors:  Yuki Higashimoto; Akane Ohta; Yukihiro Nishiyama; Masaru Ihira; Ken Sugata; Yoshizo Asano; Daniel L Peterson; Dharam V Ablashi; Paolo Lusso; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

3.  The Brief Case: Inherited Chromosomally Integrated Human Herpesvirus 6 (HHV-6) in the Age of Multiplex HHV-6 Testing.

Authors:  Alexander L Greninger; Samia N Naccache; Pia Pannaraj; Keith R Jerome; Jennifer Dien Bard; Jeanne W Ruderman
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

4.  Chromosomal integration of the HHV-6 genome as a possible cause of persistent HHV-6 detection in a patient with langerhans cell histiocytosis.

Authors:  Volker Strenger; Christian Urban
Journal:  Pathol Oncol Res       Date:  2010-03       Impact factor: 3.201

5.  Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor.

Authors:  Ioannis Politikos; Malgorzata McMasters; Christine Bryke; David Avigan; Vassiliki A Boussiotis
Journal:  Blood Adv       Date:  2018-06-26

6.  HHV6 meningoencephalitis sequelae in previously healthy children.

Authors:  E Bozzola; A Krzysztofiak; M Bozzola; V Calcaterra; A Quondamcarlo; L Lancella; A Villani
Journal:  Infection       Date:  2012-07-18       Impact factor: 3.553

Review 7.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 8.  Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.

Authors:  M Ogata; T Fukuda; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

9.  Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus.

Authors:  Caroline Breese Hall; Mary T Caserta; Kenneth C Schnabel; Lynne M Shelley; Jennifer A Carnahan; Andrea S Marino; Christina Yoo; Geraldine K Lofthus
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

Review 10.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.